1. Comparative effectiveness of sacubitril/valsartan versus angiotensin converting enzyme inhibitors/angiotensin receptor blockers in de novo heart failure patients. (3rd October 2022) Authors: Taha, I; Gomme, J; Suminska, S; Schwende, H; Butylin, D; Doherty, J; Beckmeyer-Borowko, A; Farries, G Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P6531Initiation of sacubitril/valsartan in hospitalized patients with HFrEF after hemodynamic stabilization: baseline characteristics of the TRANSITION study compared with TITRATION and PARADIGM-HF. (28th August 2018) Authors: Senni, M; Wachter, R; Belohlavek, J; Witte, K; Strabuzynska-Migaj, E; Kobalava, Z; Fonseca, C; Noe, A; Butylin, D; Schwende, H; Pascual-Figal, D Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P886Initiation of sacubitril/valsartan in hospitalized patients with heart failure with reduced ejection fraction after hemodynamic stabilization: primary results of the TRANSITION study. (28th August 2018) Authors: Wachter, R; Senni, M; Belohlavek, J; Butylin, D; Noe, A; Pascual-Figal, D Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗